BSC® Solutions
VOICES
Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 204 54" xmlns="http://www.w3.org/2000/svg"><g d="M 184.738 48 C 174.462 48 169.702 40.916 169.702 27.168 C 169.702 12.972 174.77 6 185.242 6 C 193.39 6 197.87 10.2 198.934 19.16 L 191.85 20.112 C 191.43 14.792 189.106 12.636 185.13 12.636 C 178.466 12.636 176.926 18.656 176.926 26.72 C 176.926 37.136 179.502 41.364 185.018 41.364 C 189.106 41.364 191.514 39.04 192.046 33.076 L 199.102 33.944 C 198.066 43.296 193.11 48 184.738 48 Z M 155.083 48 C 147.187 48 141.699 43.576 141.223 34.504 L 148.363 33.692 C 148.671 39.404 151.135 41.728 155.139 41.728 C 158.527 41.728 160.627 40.048 160.627 36.828 C 160.627 32.432 156.819 31.088 152.619 29.66 C 147.355 27.868 141.391 25.852 141.391 17.536 C 141.391 9.752 146.599 6 154.355 6 C 162.419 6 166.899 10.004 167.431 18.6 L 160.319 19.384 C 160.067 14.316 158.107 12.272 154.131 12.272 C 150.827 12.272 148.615 13.728 148.615 17.032 C 148.615 21.344 152.339 22.632 156.147 23.92 C 162.027 25.908 167.795 27.812 167.795 36.044 C 167.795 43.632 162.923 48 155.083 48 Z M 113.5 47.075 L 113.5 6.923 L 127.864 6.923 C 134.864 6.923 138.476 10.563 138.476 16.947 C 138.476 21.063 136.992 24.311 133.772 25.935 C 137.44 27.195 139.148 30.471 139.148 35.231 C 139.148 42.455 135.228 47.075 128.396 47.075 Z M 120.612 40.439 L 127.248 40.439 C 130.216 40.439 131.952 38.479 131.952 34.615 C 131.952 31.031 130.356 28.903 127.332 28.903 L 120.612 28.903 Z M 120.612 23.499 L 126.884 23.499 C 129.712 23.499 131.308 21.483 131.308 18.235 C 131.308 14.651 129.348 13.559 126.996 13.559 L 120.612 13.559 Z M 93.788 45.234 L 103.096 45.234 C 82.677 45.234 79.944 9 64.86 9 C 49.776 9 47.144 45.234 24.422 45.234 L 0 45.234 M 0.5 45.142 C 35.832 45.142 29.292 0 47.142 0 C 64.992 0 60.655 45.142 94.286 45.142" fill="transparent" height="48px" id="iFqsXxQ2X" transform="translate(2 3)" width="199.10199966430665px"><path d="M 71.238 42 C 60.962 42 56.202 34.916 56.202 21.168 C 56.202 6.972 61.27 0 71.742 0 C 79.89 0 84.37 4.2 85.434 13.16 L 78.35 14.112 C 77.93 8.792 75.606 6.636 71.63 6.636 C 64.966 6.636 63.426 12.656 63.426 20.72 C 63.426 31.136 66.002 35.364 71.518 35.364 C 75.606 35.364 78.014 33.04 78.546 27.076 L 85.602 27.944 C 84.566 37.296 79.61 42 71.238 42 Z M 41.583 42 C 33.687 42 28.199 37.576 27.723 28.504 L 34.863 27.692 C 35.171 33.404 37.635 35.728 41.639 35.728 C 45.027 35.728 47.127 34.048 47.127 30.828 C 47.127 26.432 43.319 25.088 39.119 23.66 C 33.855 21.868 27.891 19.852 27.891 11.536 C 27.891 3.752 33.099 0 40.855 0 C 48.919 0 53.399 4.004 53.931 12.6 L 46.819 13.384 C 46.567 8.316 44.607 6.272 40.631 6.272 C 37.327 6.272 35.115 7.728 35.115 11.032 C 35.115 15.344 38.839 16.632 42.647 17.92 C 48.527 19.908 54.295 21.812 54.295 30.044 C 54.295 37.632 49.423 42 41.583 42 Z M 0 41.075 L 0 0.923 L 14.364 0.923 C 21.364 0.923 24.976 4.563 24.976 10.947 C 24.976 15.063 23.492 18.311 20.272 19.935 C 23.94 21.195 25.648 24.471 25.648 29.231 C 25.648 36.455 21.728 41.075 14.896 41.075 Z M 7.112 34.439 L 13.748 34.439 C 16.716 34.439 18.452 32.479 18.452 28.615 C 18.452 25.031 16.856 22.903 13.832 22.903 L 7.112 22.903 Z M 7.112 17.499 L 13.384 17.499 C 16.212 17.499 17.808 15.483 17.808 12.235 C 17.808 8.651 15.848 7.559 13.496 7.559 L 7.112 7.559 Z" fill="rgb(0, 0, 0)" height="42px" id="TmpG5bKj6" transform="translate(113.5 6)" width="85.60199966430665px"/><path d="M 93.788 36.234 L 103.096 36.234 C 82.677 36.234 79.944 0 64.86 0 C 49.776 0 47.144 36.234 24.422 36.234 L 0 36.234" fill="transparent" height="36.23400000000001px" id="hDuxK1Epu" stroke-dasharray="" stroke-linecap="butt" stroke-linejoin="miter" stroke-miterlimit="10" stroke-width="3.861" stroke="rgb(0, 0, 0)" transform="translate(0 9)" width="103.096px"/><path d="M 0 45.142 C 35.332 45.142 28.792 0 46.642 0 C 64.492 0 60.155 45.142 93.786 45.142" fill="transparent" height="45.141999999999996px" id="l4coILr9Z" stroke-dasharray="" stroke-linecap="butt" stroke-linejoin="miter" stroke-miterlimit="10" stroke-width="3.861" stroke="rgb(0, 0, 0)" transform="translate(0.5 0)" width="93.786px"/></g></svg>)
Success
Conversation confirmed
let’s get prepared.
Here’s how to get the most value from our discussion and ensure it’s focused on the regulatory and clinical questions that matter most.
Prepare
for your consultation
01
Outline your program and objectives
Describe your product, development stage, and regulatory goals — including where you are in the clinical or submission lifecycle.
02
Clarify your study design and evidence strategy
Explain how evidence is currently being generated. What trial designs, endpoints, comparators, or data sources are in use — and where challenges exist?
03
Review your data and analytical landscape
Summarize the datasets available (prospective, historical, registry, or real-world) and how they are currently analyzed or prepared for regulatory review.
03
Define risk, timelines, and regulatory expectations
Share key constraints: submission timelines, FDA feedback, risk tolerance, and the level of statistical rigor required to move forward confidently.
Questions about study support, engagement models, or scope?
Want to help shape the future of clinical research?
+12158391501
hello@biomedstat.com
2400 Market Street Suite 200
Philadelphia PA, 19103
Book a free consultation
Regulatory-first biostatistics
Support built specifically for FDA-facing programs — from early feasibility through submission and post-market requirements.
Senior experts, not junior teams
Every engagement is led by experienced biostatisticians and regulatory specialists — not handed off to junior staff.
Flexible, fit-for-purpose engagements
No rigid packages. Scope exactly what you need — from focused analyses to full submission support.
Proven FDA experience
Hands-on experience across FDA pathways, statistical reviews, and regulator interactions — reducing risk and rework.
Success
Conversation confirmed
let’s get prepared.
Here’s how to get the most value from our discussion and ensure it’s focused on the regulatory and clinical questions that matter most.
Prepare
for your consultation
01
Outline your program and objectives
Describe your product, development stage, and regulatory goals — including where you are in the clinical or submission lifecycle.
02
Clarify your study design and evidence strategy
Explain how evidence is currently being generated. What trial designs, endpoints, comparators, or data sources are in use — and where challenges exist?
03
Review your data and analytical landscape
Summarize the datasets available (prospective, historical, registry, or real-world) and how they are currently analyzed or prepared for regulatory review.
03
Define risk, timelines, and regulatory expectations
Share key constraints: submission timelines, FDA feedback, risk tolerance, and the level of statistical rigor required to move forward confidently.
Questions about study support, engagement models, or scope?
Want to help shape the future of clinical research?
+12158391501
hello@biomedstat.com
2400 Market Street Suite 200
Philadelphia PA, 19103
Book a free consultation
Regulatory-first biostatistics
Support built specifically for FDA-facing programs — from early feasibility through submission and post-market requirements.
Senior experts, not junior teams
Every engagement is led by experienced biostatisticians and regulatory specialists — not handed off to junior staff.
Flexible, fit-for-purpose engagements
No rigid packages. Scope exactly what you need — from focused analyses to full submission support.
Proven FDA experience
Hands-on experience across FDA pathways, statistical reviews, and regulator interactions — reducing risk and rework.
Success
Conversation confirmed
let’s get prepared.
Here’s how to get the most value from our discussion and ensure it’s focused on the regulatory and clinical questions that matter most.
Prepare
for your consultation
01
Outline your program and objectives
Describe your product, development stage, and regulatory goals — including where you are in the clinical or submission lifecycle.
02
Clarify your study design and evidence strategy
Explain how evidence is currently being generated. What trial designs, endpoints, comparators, or data sources are in use — and where challenges exist?
03
Review your data and analytical landscape
Summarize the datasets available (prospective, historical, registry, or real-world) and how they are currently analyzed or prepared for regulatory review.
03
Define risk, timelines, and regulatory expectations
Share key constraints: submission timelines, FDA feedback, risk tolerance, and the level of statistical rigor required to move forward confidently.
Questions about study support, engagement models, or scope?
Want to help shape the future of clinical research?
+12158391501
hello@biomedstat.com
2400 Market Street Suite 200
Philadelphia PA, 19103
Book a free consultation
Regulatory-first biostatistics
Support built specifically for FDA-facing programs — from early feasibility through submission and post-market requirements.
Senior experts, not junior teams
Every engagement is led by experienced biostatisticians and regulatory specialists — not handed off to junior staff.
Flexible, fit-for-purpose engagements
No rigid packages. Scope exactly what you need — from focused analyses to full submission support.
Proven FDA experience
Hands-on experience across FDA pathways, statistical reviews, and regulator interactions — reducing risk and rework.
Success
Conversation confirmed
let’s get prepared.
Here’s how to get the most value from our discussion and ensure it’s focused on the regulatory and clinical questions that matter most.
Prepare
for your consultation
01
Outline your program and objectives
Describe your product, development stage, and regulatory goals — including where you are in the clinical or submission lifecycle.
02
Clarify your study design and evidence strategy
Explain how evidence is currently being generated. What trial designs, endpoints, comparators, or data sources are in use — and where challenges exist?
03
Review your data and analytical landscape
Summarize the datasets available (prospective, historical, registry, or real-world) and how they are currently analyzed or prepared for regulatory review.
03
Define risk, timelines, and regulatory expectations
Share key constraints: submission timelines, FDA feedback, risk tolerance, and the level of statistical rigor required to move forward confidently.
Questions about study support, engagement models, or scope?
Want to help shape the future of clinical research?
+12158391501
hello@biomedstat.com
2400 Market Street Suite 200
Philadelphia PA, 19103
Book a free consultation
Regulatory-first biostatistics
Support built specifically for FDA-facing programs — from early feasibility through submission and post-market requirements.
Senior experts, not junior teams
Every engagement is led by experienced biostatisticians and regulatory specialists — not handed off to junior staff.
Flexible, fit-for-purpose engagements
No rigid packages. Scope exactly what you need — from focused analyses to full submission support.
Proven FDA experience
Hands-on experience across FDA pathways, statistical reviews, and regulator interactions — reducing risk and rework.
Testimonials
See what our sponsors say about BSC
On Experience
Battle ground tested. There is nothing that David and team haven't seen over the years – good bad and ugly.
• VP, Clinical Operations
• CEO, Medical Device Company
• Former FDA Regulator
Let's help you find a path
to get your idea into the market
About & Services
Working With BSC
Trial Design & Methodology
Regulatory & FDA
Analysis & Programming
Cost & Contracting
Expertise & Qualifications
Practical Considerations
Common Concerns
What does BSC specialize in?
What types of clients do you work with?
What therapeutic areas do you cover?
How is BSC different from a CRO?
What size projects do you handle?
Let's help you find a path
to get your idea into the market
About & Services
Working With BSC
Trial Design & Methodology
Regulatory & FDA
Analysis & Programming
Cost & Contracting
Expertise & Qualifications
Practical Considerations
Common Concerns
What does BSC specialize in?
What types of clients do you work with?
What therapeutic areas do you cover?
How is BSC different from a CRO?
What size projects do you handle?
Let's help you find a path
to get your idea into the market
About & Services
Working With BSC
Trial Design & Methodology
Regulatory & FDA
Analysis & Programming
Cost & Contracting
Expertise & Qualifications
Practical Considerations
Common Concerns
What does BSC specialize in?
What types of clients do you work with?
What therapeutic areas do you cover?
How is BSC different from a CRO?
What size projects do you handle?
Let's help you find a path
to get your idea into the market
About & Services
Working With BSC
Trial Design & Methodology
Regulatory & FDA
Analysis & Programming
Cost & Contracting
Expertise & Qualifications
Practical Considerations
Common Concerns
What does BSC specialize in?
What types of clients do you work with?
What therapeutic areas do you cover?
How is BSC different from a CRO?
What size projects do you handle?
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Security
Robust data security and confidentiality
across sensitive, FDA-regulated clinical and regulatory data.
Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.
Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.
GDPR
SOC2 - in progress
Security
Robust data security and confidentiality
across sensitive, FDA-regulated clinical and regulatory data.
Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.
Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.
GDPR
SOC2 - in progress
Security
Robust data security and confidentiality
across sensitive, FDA-regulated clinical and regulatory data.
Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.
Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.
GDPR
SOC2 - in progress
Security
Robust data security and confidentiality
across sensitive, FDA-regulated clinical and regulatory data.
Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.
Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.
GDPR
SOC2 - in progress
Partner with us
Partner with us
Partner with us
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Use your preferred LLM to explore BSC®
Use your preferred LLM to explore BSC®